Bioproximity

Bioproximity is a privately held contract research organization located in Chantilly, Virginia, with a team of 5 to 9 employees. The company focuses on providing cutting-edge proteomic services to the biotechnology and pharmaceutical industries. They pride themselves on offering high-quality, cost-effective solutions, epitomized by their signature "$1000 Proteome" service. Bioproximity specializes in a wide range of protein analysis and informatics services, including global proteomic profiling of complex organisms, characterization of proteins and protein complexes, and clinical trial guidance utilizing protein markers. Their expertise extends to biomarker discovery and validation, particularly for targeted identification of post-translationally modified proteins like glycosylated and phosphorylated proteins. The company's commitment to innovation is evident in their comprehensive informatics analysis and expertise, enabling them to deliver insightful data interpretation and support to their clients. Bioproximity aims to be a valuable partner throughout the entire drug development process, from early biomarker discovery to clinical trial support. For more information about Bioproximity's services and expertise, visit their website at bioproximity.com.